Multi-center randomized trial on the impact of “CONFIDENCE” communication program aimed at evaluating therapy adherence of patients with registered myocardial infarction who underwent successful revascularization by stenting or thrombolysis after discharg
Published 2017-04-25
Keywords
- adherence to therapy,
- coronary heart disease,
- myocardial infarction
How to Cite
Copyright (c) 2017 Tarkova A.R., Anisimova V.D., Grazhdankin I.O., Baystrukov V.I., Zubarev D.D., Kozyr K.V., Krestyaninov O.V., Obedinskiy A.A., Prokhorikhin A.A., Kretov E.I.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Aim. The article looks at the effect of the program "Confidence" to increase the proportion of patients’ therapy in patients with coronary heart disease for two years after successful revascularization using thrombolytic or stenting of the coronary arteries on the myocardial infarction.
Methods. This is a prospective, randomized, controlled, parallel-group trial including 4.000 patients. They will be divided into two groups: patients receiving standard outpatient observation (n=2000) and those enrolled for the program "Confidence" (n=2000). The total duration is 24 months. The trial will take place in two stages. In the first stage (0-12 months) the impact of the program "Confidence" on therapy adherence and outcomes of cardiovascular diseases will be assessed. In the second stage (after the change of groups in 12 months, 12-24 months) the effect of changing the way to remind patients of therapy adherence will be evaluated.
Conclusion. The trial was designed in such a way as to show that the proposed program "Confidence" increases the proportion of patients who adhere to therapy in the cohort of those with coronary heart disease for two years after successful revascularization by using thrombolytic or stenting of the coronary arteries against the background of myocardial infarction.
Received 13 February 2017. Accepted 9 March 2017.
Financing: KRKA company’s grant. Sponsorship had no effect on data acquisition, analysis and interpretation.
Conflict of interest: Kretov E.I. served as executive editor of “Endovascular surgery” section. All other authors declare no conflict of interest.
Author contributions
Study conception and design: Kretov E.I., Grazhdankin I.O., Baystrukov V.I., Zubarev D.D.
Statistical data processing: Krestyaninov O.V., Kozyr K.V., Obedinskiy A.A., Prokhorikhin A.A.
Drafting the article: Tarkova A.R., Anisimova V.D.
Critical revision: Tarkova A.R., Anisimova V.D., Kretov E.I.
References
- Baroletti S., Dell’Orfano H. Medication adherence in cardiovascular disease. Circulation. 2010;121(12):1455-8. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.904003
- Обединский А.А., Курбатов В.П., Обединская Н.Р., Верин В.В., Кретов Е.И., Пономарев Д.Н., Покушалов Е.А. Влияние чрескожной транслюминальной коронарной ангиопластики при хронической окклюзии правой коронарной артерии на клинические характеристики и показатели стресс-МРТ в послеоперационном периоде. Патология кровообращения и кардиохирургия. 2015;19(4):48-53. http://dx.doi.org/10.21688/1681-3472-2015-4-48-53 [Obedinskii A.A., Kurbatov V.P., Obedinskaya N.R., Verin V.V., Kretov E.I., Ponomarev D.N., Pokushalov E.A. Effect of percutaneous transluminal coronary angioplasty in patients with chronic occlusion of right coronary artery on clinical characteristics and stress MRI indicators in postoperative period. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2015;19(4):48-53. (In Russ.). http://dx.doi.org/10.21688/1681-3472-2015-4-48-53]
- Bell C.M., Gunraj N., Huo C., Bierman A.S., Scales D.C., Bajcar J., Zwarenstein M., Urbach D.R. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011;306(8):840-7. http://dx.doi.org/10.1001/jama.2011.1206
- Jackevicius C.A., Li P., Tu J.V. Prevalence, predictors, and outcomes of primary non-adherence after acute myocardial infarction. Circulation. 2008;117(8):1028-36. http://dx.doi.org/10.1161/CIRCULATIONAHA.107.706820
- Ho P.M., Spertus J.A., Masoudi F.A., Reid K.J., Peterson E.D., Magid D.J., Krumholz H.M., Rumsfeld J.S. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842-7. http://dx.doi.org/10.1001/archinte.166.17.1842
- Rasmussen J.N., Chong A., Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177-86. http://dx.doi.org/10.1001/jama.297.2.177
- Nguyen T.M., Caze A.L., Cottrell N. What are validated self-report adherence scales really measuring? A systematic review. Br J Clin Pharmacol. 2014;77(3):427-45. http://dx.doi.org/10.1111/bcp.12194
- Zedler B.K., Kakad P., Colilla S., Murrelle L., Shah N.R. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther. 2011;33(1):62-73. http://dx.doi.org/10.1016/j.clinthera.2011.02.003
- Misono A.S., Cutrona S.L., Choudhry N.K., Fischer M.A., Stedman M.R., Liberman J.N., Brennan T.A., Jain S.H., Shrank W.H. Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care. 2010;16(12 Suppl HIT): SP82-92.
- Ho P.M., Lambert-Kerzner A., Carey E.P., Fahdi I.E., Bryson C.L., Melnyk S.D., Bosworth H.B., Radcliff T., Davis R., Mun H., Weaver J., Barnett C., Barón A., Del Giacco E.J. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186-93. http://dx.doi.org/10.1001/jamainternmed.2013.12944